SGThe article discusses the complexities of obesity, explaining that it is influenced by multiple factors beyond just diet and exercise. It references Dr. Bernard Tan, a medical director at Bay Medical Clinic, who emphasizes the role of hormones like GLP-1 and GIP in regulating appetite and metabolism. The World Health Organization (WHO) is cited as recognizing obesity as a chronic disease, not merely a lifestyle issue. Data from the National Population Health Survey indicates a rise in obesity rates among Singapore residents from 10.5% to 12.7% between 2019–2020 and 2023–2024. The article highlights that while healthy eating and lifestyle changes are essential, prescription medications like GLP-1-based therapies and tirzepatide—which mimic the actions of both GLP-1 and GIP hormones—are being considered for individuals whose weight issues cannot be managed through lifestyle alone. Doctors at Bay Medical Clinic emphasize the importance of combining these treatments with nutritional guidance and lifestyle modifications.
Bias read (Center): The article presents information about obesity and weight-loss treatments in a balanced manner, citing medical professionals and scientific organizations without overtly favoring any particular political stance. While the topic relates to public health policy, the focus remains on medical science, c
